プロテインエンジニアリング市場規模、シェア、成長分析：製品別、技術別、タンパク質の種類別、最終用途別、タンパク質の種類別、最終用途別、地域別 - 産業予測 2025～2032年

プロテインエンジニアリング市場規模は2023年に31億米ドルと評価され、2024年の36億4,000万米ドルから2032年には131億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは17.4％で成長する見通しです。

プロテインエンジニアリング市場は、遺伝子工学技術への投資の高まりとともに、バイオ医薬品への需要の急増によって、大きな成長が見込まれています。医療研究開発、特に慢性疾患をターゲットとしたワクチンや生物製剤への資金提供の増加は、プロテインエンジニアリングプロバイダーにとって十分な機会を創出することになるでしょう。合成生物学の台頭とプロテインエンジニアリング技術の進歩は、ビジネス成長の新たな道をさらに開くと思われます。さらに、個別化医療や標的療法に対する世界の需要が、プロテインエンジニアリング製品やサービスの販売を後押しすると予想されます。しかし、業界の成長は、プロテインエンジニアリングを取り巻く知的財産権紛争、タンパク質の安定性に関する懸念、倫理的問題などの課題に直面する可能性があり、長期的には開発の妨げになる可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

プロテインエンジニアリング市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 機器
• 試薬
• ソフトウェアとサービス

プロテインエンジニアリング市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 合理的なタンパク質設計
• 指向性進化
• ハイブリッドアプローチ
• 新規タンパク質設計
• その他

プロテインエンジニアリング市場規模：タンパク質の種類別& CAGR（2025-2032）

• 市場概要
• インスリン
• モノクローナル抗体
• ワクチン
• 成長因子
• コロニー刺激因子
• 凝固因子
• インターフェロン
• その他

プロテインエンジニアリング市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 学術調査機関
• 契約調査機関（CRO）
• 製薬・バイオテクノロジー企業

プロテインエンジニアリング市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• Genscript Biotech Corporation（China）
• Codexis, Inc.（US）
• Danaher Corporation（US）
• Bio-Rad Laboratories, Inc.（US）
• Bruker Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• New England Biolabs（US）
• Genentech, Inc.（US）
• Promega Corporation（US）
• Sutro Biopharma, Inc.（US）
• Abcam plc.（UK）
• Cyrus Biotechnology, Inc.（US）
• Profacgen（US）
• Creative Biomart（US）
• SeSaM-Biotech GmbH（Germany）

結論と提言

Protein Engineering Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 13.13 billion by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The protein engineering market is poised for significant growth, driven by the surging demand for biopharmaceuticals alongside escalating investments in genetic engineering technologies. Increased funding for medical R&D, particularly for vaccines and biologics targeting chronic diseases, is set to create ample opportunities for protein engineering providers. The rise of synthetic biology and advancements in protein engineering techniques will further open new avenues for business growth. Additionally, the global demand for personalized medicine and targeted therapies is anticipated to boost the sale of protein engineering products and services. However, industry growth may face challenges from intellectual property disputes, protein stability concerns, and ethical issues surrounding protein engineering, which could hinder development in the long term.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Engineering market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Engineering Market Segments Analysis

Global Protein Engineering Market is segmented by Product, Technology, Protein Type, End Use and region. Based on Product, the market is segmented into Instruments, Reagents and Software & Services. Based on Technology, the market is segmented into Rational Protein Design, Directed Evolution, Hybrid Approach, De Novo Protein Design and Others. Based on Protein Type, the market is segmented into Insulin, Monoclonal Antibodies, Vaccines, Growth Factors, Colony Stimulating Factors, Coagulation Factors, Interferon and Others. Based on End Use, the market is segmented into Academic Research Institutes, Contract Research Organizations (CROs) and Pharmaceutical &biotechnology companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Engineering Market

The rising trend of personalized medicine has gained significant traction globally, as individuals seek more targeted and effective treatment options for their health issues. As the understanding of genetic influences on diseases becomes increasingly refined, the demand for personalized therapeutic solutions has surged. This evolution in medical treatment is heavily reliant on protein engineering, which is essential for creating tailored therapies. Consequently, the expanding interest in personalized medicine directly contributes to the growth and expansion opportunities for companies operating within the protein engineering sector, highlighting the interdependence between these two fields in advancing healthcare innovation.

Restraints in the Protein Engineering Market

The Protein Engineering market faces significant challenges primarily due to the complexities involved in achieving desirable stability and functionality in proteins. The intricate nature of proteins makes it difficult to preserve their therapeutic properties, as they are prone to denaturation or aggregation. Such alterations can significantly diminish their effectiveness, hindering the development of innovative protein-based products. Consequently, these challenges may impede the growth potential of the market, as efforts to create stable and functional proteins are met with obstacles that complicate research and development within this sector, ultimately affecting overall market progress.

Market Trends of the Protein Engineering Market

The protein engineering market is witnessing a significant trend towards the adoption of directed evolution techniques, which leverage principles of natural selection in laboratory settings. This innovative approach enables companies to develop novel protein variants that are not purely synthetic, expanding the potential applications across various domains, including therapeutics for chronic diseases. The ability to rapidly generate diverse protein libraries enhances research capabilities, driving collaborations between academia and industry. As the demand for tailored biopharmaceuticals and precision medicine continues to rise, the incorporation of directed evolution is positioning protein engineering as a key player in addressing complex healthcare challenges, shaping a dynamic market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Protein Engineering Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents
• Software & Services

Global Protein Engineering Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Rational Protein Design
• Directed Evolution
• Hybrid Approach
• De Novo Protein Design
• Others

Global Protein Engineering Market Size by Protein Type & CAGR (2025-2032)

• Market Overview
• Insulin
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Colony Stimulating Factors
• Coagulation Factors
• Interferon
• Others

Global Protein Engineering Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies

Global Protein Engineering Market Size & CAGR (2025-2032)

• North America (Product, Technology, Protein Type, End Use)
  • US
  • Canada
• Europe (Product, Technology, Protein Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Protein Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Protein Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Protein Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sutro Biopharma, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyrus Biotechnology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profacgen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biomart (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeSaM-Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations